Clinical and molecular epidemiology of beta-hemolytic streptococcal infections in India

Autores: Mathur Purva, Bhardwaj Nidhi, Mathur Kushal, Behera Bijayini, Gupta Gunjan, Kapil Arti, Singh Sarman, Misra Mahesh C

Resumen

Introduction: Beta-hemolytic streptococci (âHS) cause a diverse array of human infections. Despite the high number of cases of streptococcal carriers and diseases, studies discerning the molecular epidemiology of âHS in India are limited. This study reports the molecular and clinical epidemiology of beta-hemolytic streptococcal infections from two geographically distinct regions of India. Methodology: A total of 186 isolates of âHS from north and south India were included. The isolates were identified to species level and subjected to antimicrobial susceptibility testing. Polymerase chain reaction (PCR) was done to detect exotoxin genes and emm types of group A streptococci (GAS) strains were ascertained by sequencing. Results: GAS was the most common isolate (71.5%), followed by group G streptococci (GGS) (21%). A large proportion of GAS produced speB (97%), smeZ (89%), speF (91%), and speG (84%). SmeZ was produced by 21% and 50% of GGS and GGS, respectively. A total of 45 different emm types/subtypes were seen in GAS, withemm 11 being the most common. Resistance to tetracycline (73%) and erythromycin (34.5%) was commonly seen in GAS. Conclusions: A high diversity of emm types was seen in Indian GAS isolates with high macrolide and tetracycline resistance. SpeA was less commonly seen in Indian GAS isolates. There was no association between disease severity and exotoxin gene production.

Palabras clave: Beta-hemolytic streptococci; group A streptococcus; Spe; emm types; antimicrobial resistance.

2014-03-13   |   539 visitas   |   5 valoraciones

Vol. 8 Núm.3. Marzo 2014 Pags. 297-303 J Infect Developing Countries 2014; 8(3)